Immunotherapy injected directly into fluid cavities shows promise for pancreatic cancer
Disease control
Not yet recruiting
This phase 2 trial tests whether putting an immunotherapy drug called adebrelimab directly into the chest or belly can help control cancer-related fluid buildup in people with advanced pancreatic cancer. About 20 participants will receive the drug along with standard care. The go…
Phase: PHASE2 • Sponsor: Sizhen Wang • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC